Share this page: More

Pharmacology Faculty

Training Program Faculty

Our training faculty are made up of primary faculty in Pharmacology and Molecular Sciences as well as faculty from a variety of other departments at Johns Hopkins who have research interests in (among others) oncology, virology, immunology, chemistry, chemical biology, and clinical pharmacology.


Primary Faculty

Netz Arroyo, Ph.D., Assistant Professor
Exploiting biology-inspired electrochemical sensing to study the fate of molecules in the body.

James C. Barrow, Ph.D., Associate Professor
Drug discovery for disorders of neurodevelopment.

Namandjé N. Bumpus, Ph.D., Director and E.K. Marshall and Thomas H. Maren Professor
Drug Metabolism and preclinical drug development; small molecule mass spectrometry; targeted metabolomics; antiviral drug-induced toxicity; modulation of cellular signaling pathways by reactive metabolites.

Gregory V. Carr, Ph.D., Assistant Professor
Preclinical models of neurological and psychiatric disorders.

Jun O. Liu, Ph.D., Professor
Chemical biology and molecular biology; use of small molecules as probes to elucidate mechanisms of signal transduction; angiogenesis and cell proliferation.

Caren L. Freel Meyers, Ph.D., Professor
Organic and medicinal chemistry, chemical biology: drug delivery; study of non-mammalian isoprenoid biosynthesis; development of potential therapeutic agents for cancer and infectious disease.

Ronald L. Schnaar, Ph.D., Professor
Cellular regulation by glycans in the nervous and immune systems.

James T. Stivers, Ph.D., Professor
Structural and Chemical Biology of Uracil Metabolism and Applications to Cancer Therapy, Innate and Adaptive Immunity.

Sean D. Taverna, Ph.D., Associate Professor
Histone and chromatin modifications, epigenetics and gene function, identification of histone binding modules, and small RNA directed gene silencing.

Heng Zhu, Ph.D., Professor
Signal Transduction; protein network; host-pathogen interaction; biomarker identification.

Other Training Program Faculty

Richard F. Ambinder, M.D., Ph.D., Professor (Secondary)
Virology and human cancer; antiviral therapy; antitumor therapy; lymphoma pathogenesis and treatment; immunological approaches to virus-associated malignancies.

L. Mario Amzel, Ph.D., Professor
3-D structure of proteins: immunoglobulins and other binding proteins; ATP synthase; monoxygenases and dioxygenases quinone reductase.

James M. Berger, Ph.D., Professor (Secondary)
Structural and catalytic mechanisms of nucleic-acid machines and assemblies; control of DNA replication and chromosome superstructure; small-molecule and biological regulatory mechanisms.

Kristin L. Bigos, Ph.D., Assistant Professor (Secondary)
Using neuroimaging and genetics to develop better drugs for psychiatry.

Ted M. Dawson, M.D., Ph.D., Professor (Secondary)
Molecular and cellular signals controlling neurodegeneration, neuronal survival and cell death.

Samuel R. Denmeade, M.D., Professor (Secondary)
Targeted therapies for cancer; prodrugs; proteases; peptide libraries.

Kelly E. Dooley, M.D., Ph.D., Professor (Secondary)
Clinical pharmacology of anti-infective agents; Evaluation of new drug regimens for the treatment of tuberculosis and co-treatment of TB and HIV.

Laura M. Ensign, Ph.D., Associate Professor (Secondary)
Nanomedicine for drug delivery.

Marc M. Greenberg, Ph.D., Professor
Chemical and biochemical approaches to the study of DNA damage and repair, and their applications.

Justin Hanes, Ph.D., Professor (Secondary)
Nanotechnology for Drug and Nucleic Acid Delivery.

J. Marie Hardwick, Ph.D.,Professor (Joint)
Molecular mechanisms of cell death.

Ling He, M.D., Ph.D., Associate Professor (Secondary)
Coactivators regulate metabolism and mitochondrial function.

Craig W. Hendrix, M.D., Professor (Secondary)
Prevention of HIV infection.

Richard L. Huganir, Ph.D., Professor
Molecular mechanisms in the regulation of synaptic plasticity.

Takanari Inoue, Ph.D., Professor (Secondary)
Cell Biology: Total synthesis of cellular functions such as neutrophil chemotaxis and ciliary mechano-sensation.

Matthew M. Ippolito, M.D., Assistant Professor (Secondary)
Chemotherapeutics for malaria control and elimination.

John T. Isaacs, Ph.D., Professor
Anti-cancer drug development; Normal and malignant stem cell biology.

William B. Isaacs, Ph.D., Professor
Understanding the molecular genetic events responsible for initiation and progression of prostate cancer, with particular interest in inherited susceptibility to prostate cancer.

David A. Kass, M.D., Professor (Secondary)
Molecular physiology of myocardial disease.

Kenneth W. Kinzler, Ph.D., Professor
Molecular genetics of cancer, translational cancer research.

Mark Levis, M.D., Ph.D., Professor
Targeting the FLT3 signaling pathway as a treatment for acute leukemia.

William G. Nelson, M.D., Ph.D., Professor (Secondary)
DNA methylation and epigenetic gene silencing; inflammation and prostatic carcinogenesis.

Sridhar Nimmagadda, Ph.D., Associate Professor (Secondary)
Chemokine receptor biology and molecular imaging applications in drug development.

Kenneth J. Pienta, M.D., Professor (Secondary)
The ecology of cancer, tumor microenvironment, metastasis, biomarker development, novel therapeutic development.

Martin G. Pomper, M.D., Ph.D., Professor (Secondary)
Translational precision imaging.

Jonathan D. Powell, M.D., Ph.D., Professor (Secondary)
Mechanisms of T cell activation and tolerance.

Stuart C. Ray, M.D., Professor
Computational immunovirology of chronic viral hepatitis.

Douglas N. Robinson, Ph.D., Professor (Secondary)
Understanding cytokinesis and cell shape control.

Christopher A. Ross, M.D., Ph.D., Professor (Secondary)
Neuropsychiatric disorders.

Theresa A. Shapiro, M.D., Ph.D., Professor (Secondary)
Clinical pharmacology; molecular mechanisms of antiparasitic drug action; effects of topoisomerase inhibitors on DNA of trypanosomes; structure-activity of synthetic antimalarial trioxanes.

Robert F. Siliciano, M.D., Ph.D., Professor (Secondary)
HIV latency, evolution, and persistence; HIV treatment and drug resistance; pharmacology of HIV drugs.

Barbara S. Slusher, Ph.D., M.A.S., Professor
Johns Hopkins Drug Discovery (JHDD)

Solomon H. Snyder, M.D., Professor (Secondary)
Molecular basis of neural signal transduction.

Saraswati Sukumar, Ph.D., Professor
Molecular alterations in breast cancer.

Craig A. Townsend, Ph.D., Professor
Organic and bioorganic chemistry: biosynthesis of natural products and biomimetic synthesis; elucidation of protein function; molecular biology of secondary metabolism and engineering of biosynthetic systems to practical ends; study of the role and inhibition of fatty acid synthesis in human cancer, tuberculosis, and obesity.

Bert Vogelstein, M.D., Professor
Molecular genetics of human cancer.

Huijun Wei, Ph.D., Assistant Professor (Secondary)
Identifying and validating drug targets for the treatment of neurodevelopmental disorders.

Ethel D. Weld, M.D., Ph.D., Assistant Professor (Secondary)
Alternative delivery strategies for HIV prevention and treatment, and expanding treatment options for special populations with TB and HIV.

Michael J. Wolfgang, Ph.D., Professor (Secondary)
Cellular and organismal metabolism.

Srinivasan Yegnasubramanian, M.D., Ph.D., Associate Professor
Understanding and exploiting alterations in the cancer genome and epigenome for development of biomarkers and therapeutics.

Return to Top


Other Associated Faculty

Philip A. Cole M.D., Ph.D., Professor (Adjunct)
Chemical and biochemical approaches in the study of signal transduction, circadian rhythm, and gene regulation.

Albena Dinkova-Kostova, Ph.D., Professor (Adjunct)
Protection against cancer mechanisms and strategies; structure-activity relation of protective agents; inflammation and cancer; skin cancer prevention.

Charles W. Flexner, M.D., Professor (Secondary Appointment)
Basic and clinical pharmacology of antiretroviral drugs; HIV protease inhibitors and entry inhibitors.

Wade Gibson, Ph.D., Professor Emeritus (Primary Appointment)
Herpesvirus proteins: studies of their expression, structure, and function using genetic, biochemical, and immunological approaches.

Gary S. Hayward, Ph.D., Professor (Secondary Appointment)
Pathways of herpesvirus gene regulation, latency and pathogenesis; enhancer and silencer elements that modulate gene expression; mechanisms of positive and negative transcriptional regulation; interaction with and targeting to subnuclear domains by viral regulatory proteins; molecular piracy and promotion of angiogenesis by Kaposi's sarcoma herpesvirus; virus evasion of interferon-mediated innate immunity; virus evolution and virus hunting.

Brent Petty, M.D., Associate Professor (Secondary Appointment)
Antimicrobial chemotherapy; hospital-based medical practices; internal medicine collaboration with ophthalmologic clinical trials.

Mark A Schenerman, Professor (Adjunct)
Development of biopharmaceuticals to address infectious disease and cancer.

Johannes N. van den Anker, M.D., Ph.D., Professor (Adjunct)
Department of Pediatrics
The George Washington University School of Medicine and Health Sciences

Amina S. Woods, Ph.D., Professor (Adjunct)
Structural Biology Unit, Cellular Neurobiology


Return to Top